Kelly Thomas Patrick bought XENE
October 15, 2025 · Form 4 insider transaction
Kelly Thomas Patrick bought 225,000 shares of Xenon Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
225,000
Price
$0.00
Total value
N/A
InsiderKelly Thomas Patrick
RoleOfficer
SecurityShare Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 15, 2025
Filing dateOctober 17, 2025
Shares owned after225,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Vesting 25% on October 15, 2026, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.